aluates Reports

$ 0.0

Automative

Global Drugs for Malaria Market Research Report 2026

Published Date: 2026-02-06

Report Code: QYRE-Auto-O228

Global Drugs for Malaria Market Insights and Forecast to 2027

BUY CHAPTERS

Global Drugs for Malaria Market Research Report 2026

Code: QYRE-Auto-O228

Report

2026-02-06

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Cipla Ltd

Guilin Pharmaceutical

Ipca Laboratories

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

GlaxoSmithKline

GlaxoSmithKline PLC

Mylan Labs

Drugs for Malaria Market

The global Drugs for Malaria market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician"s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

This report delivers a comprehensive overview of the global Drugs for Malaria market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs for Malaria. The Drugs for Malaria market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drugs for Malaria market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drugs for Malaria manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drugs for Malaria Market Report

Report Metric	Details
Report Name	Drugs for Malaria Market
Segment by Type	Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds
Segment by Application	Prevention Treatment Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drugs for Malaria companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Drugs for Malaria Market report?

Ans: The main players in the Drugs for Malaria Market are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma

What are the Application segmentation covered in the Drugs for Malaria Market report?

Ans: The Applications covered in the Drugs for Malaria Market report are Prevention, Treatment, Others

What are the Type segmentation covered in the Drugs for Malaria Market report?

Ans: The Types covered in the Drugs for Malaria Market report are Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Aryl Aminoalcohol Compounds

1.2.3 Antifolate Compounds

1.2.4 Artemisinin Compounds

1.3 Market by Application

1.3.1 Global Drugs for Malaria Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Prevention

1.3.3 Treatment

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drugs for Malaria Market Perspective (2021–2032)

2.2 Global Drugs for Malaria Growth Trends by Region

2.2.1 Global Drugs for Malaria Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drugs for Malaria Historic Market Size by Region (2021–2026)

2.2.3 Drugs for Malaria Forecasted Market Size by Region (2027–2032)

2.3 Drugs for Malaria Market Dynamics

2.3.1 Drugs for Malaria Industry Trends

2.3.2 Drugs for Malaria Market Drivers

2.3.3 Drugs for Malaria Market Challenges

2.3.4 Drugs for Malaria Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drugs for Malaria Players by Revenue

3.1.1 Global Top Drugs for Malaria Players by Revenue (2021–2026)

3.1.2 Global Drugs for Malaria Revenue Market Share by Players (2021–2026)

3.2 Global Top Drugs for Malaria Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drugs for Malaria Revenue

3.4 Global Drugs for Malaria Market Concentration Ratio

3.4.1 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2025

3.5 Global Key Players of Drugs for Malaria Head Offices and Areas Served

3.6 Global Key Players of Drugs for Malaria, Products and Applications

3.7 Global Key Players of Drugs for Malaria, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drugs for Malaria Breakdown Data by Type

4.1 Global Drugs for Malaria Historic Market Size by Type (2021–2026)

4.2 Global Drugs for Malaria Forecasted Market Size by Type (2027–2032)

5 Drugs for Malaria Breakdown Data by Application

5.1 Global Drugs for Malaria Historic Market Size by Application (2021–2026)

5.2 Global Drugs for Malaria Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drugs for Malaria Market Size (2021–2032)

6.2 North America Drugs for Malaria Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drugs for Malaria Market Size by Country (2021–2026)

6.4 North America Drugs for Malaria Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drugs for Malaria Market Size (2021–2032)

7.2 Europe Drugs for Malaria Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drugs for Malaria Market Size by Country (2021–2026)

7.4 Europe Drugs for Malaria Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drugs for Malaria Market Size (2021–2032)

8.2 Asia-Pacific Drugs for Malaria Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drugs for Malaria Market Size by Region (2021–2026)

8.4 Asia-Pacific Drugs for Malaria Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drugs for Malaria Market Size (2021–2032)

9.2 Latin America Drugs for Malaria Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drugs for Malaria Market Size by Country (2021–2026)

9.4 Latin America Drugs for Malaria Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drugs for Malaria Market Size (2021–2032)

10.2 Middle East & Africa Drugs for Malaria Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drugs for Malaria Market Size by Country (2021–2026)

10.4 Middle East & Africa Drugs for Malaria Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cipla

11.1.1 Cipla Company Details

11.1.2 Cipla Business Overview

11.1.3 Cipla Drugs for Malaria Introduction

11.1.4 Cipla Revenue in Drugs for Malaria Business (2021–2026)

11.1.5 Cipla Recent Development

11.2 Guilin Pharmaceutical

11.2.1 Guilin Pharmaceutical Company Details

11.2.2 Guilin Pharmaceutical Business Overview

11.2.3 Guilin Pharmaceutical Drugs for Malaria Introduction

11.2.4 Guilin Pharmaceutical Revenue in Drugs for Malaria Business (2021–2026)

11.2.5 Guilin Pharmaceutical Recent Development

11.3 IPCA Laboratories

11.3.1 IPCA Laboratories Company Details

11.3.2 IPCA Laboratories Business Overview

11.3.3 IPCA Laboratories Drugs for Malaria Introduction

11.3.4 IPCA Laboratories Revenue in Drugs for Malaria Business (2021–2026)

11.3.5 IPCA Laboratories Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Drugs for Malaria Introduction

11.4.4 GlaxoSmithKline Revenue in Drugs for Malaria Business (2021–2026)

11.4.5 GlaxoSmithKline Recent Development

11.5 Mylan Labs

11.5.1 Mylan Labs Company Details

11.5.2 Mylan Labs Business Overview

11.5.3 Mylan Labs Drugs for Malaria Introduction

11.5.4 Mylan Labs Revenue in Drugs for Malaria Business (2021–2026)

11.5.5 Mylan Labs Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Drugs for Malaria Introduction

11.6.4 Roche Revenue in Drugs for Malaria Business (2021–2026)

11.6.5 Roche Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Drugs for Malaria Introduction

11.7.4 Novartis Revenue in Drugs for Malaria Business (2021–2026)

11.7.5 Novartis Recent Development

11.8 Sanofi Aventis

11.8.1 Sanofi Aventis Company Details

11.8.2 Sanofi Aventis Business Overview

11.8.3 Sanofi Aventis Drugs for Malaria Introduction

11.8.4 Sanofi Aventis Revenue in Drugs for Malaria Business (2021–2026)

11.8.5 Sanofi Aventis Recent Development

11.9 Ajanta Pharma

11.9.1 Ajanta Pharma Company Details

11.9.2 Ajanta Pharma Business Overview

11.9.3 Ajanta Pharma Drugs for Malaria Introduction

11.9.4 Ajanta Pharma Revenue in Drugs for Malaria Business (2021–2026)

11.9.5 Ajanta Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Cipla Ltd

Guilin Pharmaceutical

Ipca Laboratories

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

GlaxoSmithKline

GlaxoSmithKline PLC

Mylan Labs

List of Tables

Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Aryl Aminoalcohol Compounds

Table 3. Key Players of Antifolate Compounds

Table 4. Key Players of Artemisinin Compounds

Table 5. Global Drugs for Malaria Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Drugs for Malaria Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Drugs for Malaria Market Size by Region (US$ Million), 2021–2026

Table 8. Global Drugs for Malaria Market Share by Region (2021–2026)

Table 9. Global Drugs for Malaria Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Drugs for Malaria Market Share by Region (2027–2032)

Table 11. Drugs for Malaria Market Trends

Table 12. Drugs for Malaria Market Drivers

Table 13. Drugs for Malaria Market Challenges

Table 14. Drugs for Malaria Market Restraints

Table 15. Global Drugs for Malaria Revenue by Players (US$ Million), 2021–2026

Table 16. Global Drugs for Malaria Market Share by Players (2021–2026)

Table 17. Global Top Drugs for Malaria Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drugs for Malaria Revenue, 2025

Table 18. Ranking of Global Top Drugs for Malaria Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Drugs for Malaria Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Drugs for Malaria, Headquarters and Area Served

Table 21. Global Key Players of Drugs for Malaria, Products and Applications

Table 22. Global Key Players of Drugs for Malaria, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Drugs for Malaria Market Size by Type (US$ Million), 2021–2026

Table 25. Global Drugs for Malaria Revenue Market Share by Type (2021–2026)

Table 26. Global Drugs for Malaria Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Drugs for Malaria Revenue Market Share by Type (2027–2032)

Table 28. Global Drugs for Malaria Market Size by Application (US$ Million), 2021–2026

Table 29. Global Drugs for Malaria Revenue Market Share by Application (2021–2026)

Table 30. Global Drugs for Malaria Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Drugs for Malaria Revenue Market Share by Application (2027–2032)

Table 32. North America Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Drugs for Malaria Market Size by Country (US$ Million), 2021–2026

Table 34. North America Drugs for Malaria Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Drugs for Malaria Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Drugs for Malaria Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Drugs for Malaria Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Drugs for Malaria Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Drugs for Malaria Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Drugs for Malaria Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Drugs for Malaria Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Drugs for Malaria Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Drugs for Malaria Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Drugs for Malaria Market Size by Country (US$ Million), 2027–2032

Table 47. Cipla Company Details

Table 48. Cipla Business Overview

Table 49. Cipla Drugs for Malaria Product

Table 50. Cipla Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 51. Cipla Recent Development

Table 52. Guilin Pharmaceutical Company Details

Table 53. Guilin Pharmaceutical Business Overview

Table 54. Guilin Pharmaceutical Drugs for Malaria Product

Table 55. Guilin Pharmaceutical Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 56. Guilin Pharmaceutical Recent Development

Table 57. IPCA Laboratories Company Details

Table 58. IPCA Laboratories Business Overview

Table 59. IPCA Laboratories Drugs for Malaria Product

Table 60. IPCA Laboratories Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 61. IPCA Laboratories Recent Development

Table 62. GlaxoSmithKline Company Details

Table 63. GlaxoSmithKline Business Overview

Table 64. GlaxoSmithKline Drugs for Malaria Product

Table 65. GlaxoSmithKline Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 66. GlaxoSmithKline Recent Development

Table 67. Mylan Labs Company Details

Table 68. Mylan Labs Business Overview

Table 69. Mylan Labs Drugs for Malaria Product

Table 70. Mylan Labs Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 71. Mylan Labs Recent Development

Table 72. Roche Company Details

Table 73. Roche Business Overview

Table 74. Roche Drugs for Malaria Product

Table 75. Roche Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 76. Roche Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Drugs for Malaria Product

Table 80. Novartis Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 81. Novartis Recent Development

Table 82. Sanofi Aventis Company Details

Table 83. Sanofi Aventis Business Overview

Table 84. Sanofi Aventis Drugs for Malaria Product

Table 85. Sanofi Aventis Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 86. Sanofi Aventis Recent Development

Table 87. Ajanta Pharma Company Details

Table 88. Ajanta Pharma Business Overview

Table 89. Ajanta Pharma Drugs for Malaria Product

Table 90. Ajanta Pharma Revenue in Drugs for Malaria Business (US$ Million), 2021–2026

Table 91. Ajanta Pharma Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Drugs for Malaria Picture

Figure 2. Global Drugs for Malaria Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drugs for Malaria Market Share by Type: 2025 vs 2032

Figure 4. Aryl Aminoalcohol Compounds Features

Figure 5. Antifolate Compounds Features

Figure 6. Artemisinin Compounds Features

Figure 7. Global Drugs for Malaria Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Drugs for Malaria Market Share by Application: 2025 vs 2032

Figure 9. Prevention Case Studies

Figure 10. Treatment Case Studies

Figure 11. Others Case Studies

Figure 12. Drugs for Malaria Report Years Considered

Figure 13. Global Drugs for Malaria Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Drugs for Malaria Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Drugs for Malaria Market Share by Region: 2025 vs 2032

Figure 16. Global Drugs for Malaria Market Share by Players in 2025

Figure 17. Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Drugs for Malaria Revenue in 2025

Figure 19. North America Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Drugs for Malaria Market Share by Country (2021–2032)

Figure 21. United States Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Drugs for Malaria Market Share by Country (2021–2032)

Figure 25. Germany Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Drugs for Malaria Market Share by Region (2021–2032)

Figure 33. China Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Drugs for Malaria Market Share by Country (2021–2032)

Figure 41. Mexico Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Drugs for Malaria Market Share by Country (2021–2032)

Figure 45. Israel Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Drugs for Malaria Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Cipla Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 49. Guilin Pharmaceutical Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 50. IPCA Laboratories Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 52. Mylan Labs Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 53. Roche Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 54. Novartis Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 55. Sanofi Aventis Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 56. Ajanta Pharma Revenue Growth Rate in Drugs for Malaria Business (2021–2026)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Malaria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Artemisinin Antimalarial Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Primaquine Market Research Report 2025

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Termite Drug Market Research Report 2024

Global Anti Mosquito Products Market Research Report 2025

Global Mefloquine Market Research Report 2025

Global Anti tumor Drug Market Research Report 2025

Global Anti AIDs Drug Market Insights Forecast to 2030

Global Marine based Drug Market Research Report 2024

Global Malaria Ag Rapid Testing Market Research Report 2024

Global Topical Medication Market Research Report 2024

Global Anti anemia Drugs Market Research Report 2024

Chloroquine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dermatology Drug Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global BCC Drug Market Research Report 2024

Global Insulin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Miscellaneous Antimalarials Market Research Report 2024

Malaria Ag Rapid Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions